Dexcom

Extracted Attributes

• Founded

  1999-01-01

• Industry

  Healthcare and Medical Devices

• Products

  Dexcom G6, Dexcom G7, Dexcom ONE+, Stelo, Dexcom Share, Dexcom Follow, Dexcom Clarity

• Global Reach

  Available in 52 countries worldwide

• Headquarters

  San Diego, California, United States

• Stock Ticker

  DXCM

• Employee Count

  Over 8,000 employees (as of December 2020)

• Manufacturing Locations

  Mesa (Arizona, USA), Batu Kawan (Malaysia), Athenry (County Galway, Ireland)

Timeline

• Dexcom was founded and incorporated to develop glucose biosensing technology. (Source: Wikidata)

  1999-01-01

• Dexcom introduced the first continuous glucose monitoring (CGM) system to the world. (Source: Web Search (Dexcom About Us))

  2006-01-01

• Dexcom reported availability in 52 countries and a global workforce exceeding 8,000 employees. (Source: Web Search (Dexcom About Us))

  2020-12-31

• Morgan Stanley identified as engineering spread trades to short Dexcom due to the impact of GLP-1 agonists. (Source: Document 0d1b8bf2-4839-4e94-af1e-1c882a1d8877)

  2023-10-20

• Dexcom adds enhanced smart meal logging features to its Stelo biosensor system. (Source: Web Search (Yahoo Finance))

  2026-02-04

• Dexcom reports its fourth quarter and fiscal year 2025 financial results. (Source: Web Search (Yahoo Finance))

  2026-02-12

Dexcom

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Web Search Results

• DexCom, Inc. (DXCM) Company Profile & Facts

  DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. [...] - Day losers - Highest open interest - Highest implied volatility + Sectors - Technology - Financial services - Consumer cyclical - Communication services - Healthcare - Industrials - Consumer defensive - Energy - Basic materials - Real estate - Utilities + Treasury bonds + Futures + Currencies + World indices + ETFs Research + Stock picks + Screeners - Stocks - Most shorted - Most active penny stocks - Analyst strong buy + Calendar - Earnings - Stock splits - IPOs - Economic events + Stock comparison - NVDA vs INTC - NVDA vs AMD - GOOG vs AMZN - AAPL vs MSFT - TSLA vs RIVN + Currency converter + Advanced charts + Investment ideas + Research reports [...] My Portfolio News + Latest + Originals + Premium news + Newsletters + Stock market + Crypto + Earnings + Tariffs + Tax Insights via H&R Block + More Topics - Economies - Tech - Housing Markets + Stocks - Most active - Day gainers - Day losers - Trending - Highest dividend - Small cap - Large cap - Most expensive - Highest beta - Pink sheet - Unusual volume + Crypto - Most active - Day gainers - Day losers + Prediction markets - Finance - Crypto - Equities - Earnings - Tech - Economy + Private companies - 52 week gainers - Recently funded - Most funded + Options - Day gainers - Day losers - Highest open interest

• DexCom, Inc. - Investor Relations

  1. JAMA. 2017;317(4):371-378. 2. Welsh, J.B. et al (2019). "Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems." Diabetes Technol Ther 21(3) Dexcom, Dexcom G6, Dexcom Share, and Dexcom CLARITY are registered trademarks of Dexcom, Inc. in the United States and/or other countries. If your glucose alerts and readings from the G6 or G7 CGM Systems do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Privacy Policy Terms of Use © 2026 Q4 Inc. - All rights reserved Powered By Q4 Inc.5.173.0.1(opens in new window) [...] ### Corporate Overview Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently. Our Mission: Empowering People to Take Control of Health Image 3: people holding up dexcom products on cell phones Press Releases Feb 12, 2026 Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results Read More Feb 04, 2026 Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management Read More Jan 27, 2026 [...] DexCom, Inc. - Investor Relations Overview News Events & Presentations Stock Info Back Stock Quote Stock Chart Historical Stock Quote Investment Calculator Financials Back Quarterly Results Annual Reports SEC Filings Governance Back Governance Documents & Sustainability Executive Management Board of Directors Committee Composition Sustainability Back Overview Listen Think Big Be Dependable Serve With Integrity Resources Back Investor Email Alerts Investor Contacts

• About Dexcom

  Dexcom, Dexcom G6, Dexcom G7, Dexcom G5 Mobile, Dexcom G4, Dexcom Follow, Dexcom Share and Dexcom Clarity are registered trademarks of Dexcom Inc. in the U.S. and may be registered in other countries. LBL-1001709 Rev001 • LBL-1001520 Rev001 © 2026 Dexcom Canada, Co. All rights reserved. This product is covered by US Patent. Image 8: CA flag CA Change region [...] When you visit our website, we store cookies on your browser to collect information about you, your preferences, or your device to make the site work as you expect and to provide a more personalized web experience. We may share information about your use of our website with our advertising and analytics partners. You can opt out of certain types of cookies, but that may impact your experience of our website and the services we are able to offer. However, you cannot opt out of our strictly necessary cookies as they ensure the proper functioning of our website (for example, prompting the cookie banner and remembering your settings, allowing you to log into your account, and redirecting you when you log out). To opt out of the use or sharing of your personal information for targeted

• Compare CGM Systems | Dexcom G7 vs G6

  # explore and compare Dexcom CGM products. The Dexcom CGM portfolio is a growing line of personal and professional products that support a broad range of people with diabetes. Now you can simply prescribe the powerful CGM system that works best for your patients’ individual needs. ### Use of Dexcom CGM Helps Your Patients With: #### Improvements in key outcomes1-5 #### Advanced monitoring helps prevent hypoglycemic events6 #### Powerfully accurate numbers without fingersticks,\ scans, or calibration7 #### Painless sensor insertion†,7 Compare Dexcom CGM Products \If your glucose alerts and readings from Dexcom CGM do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. †Patients reported 95% of insertions were painless (mild, no pain). [...] | Components and Features | Dexcom G7 | Dexcom G6 Personal | Dexcom G6 Pro | --- --- | | System | | | | | Indication | 2 years and older | 2 years and older | 2 years and older | | Wear duration | Up to 10 days | Up to 10 days | Up to 10 days per person | | Calibration | None required | None required | None required | | Mode | Unblinded | Unblinded | Blinded or Unblinded | | Dosing | Nonadjunctive | Nonadjunctive | Nonadjunctive (unblinded mode only) | | Reporting Software | | | | | CLARITY | Yes | Yes | Yes | | Display (unblinded mode) | | | | | Device‡ | Smart device or receiver | Smart device or receiver | Smart phone | | Alerts and Alarm | Quiet Mode Delayed 1st Alert Urgent Low Alert | Advanced features Urgent Low Alarm | Urgent Low Alarm | [...] ## an integrated system for diabetes management Dexcom products and software provide you with more insight into individualized treatment plans, offering more ways to help inform patients’ daily diabetes treatment decisions. ### Dexcom CGM We offer a range of highly accurate CGM systems that help more people with diabetes better manage their glucose levels and improve their health.6 Compare CGM Products ### Dexcom Apps Our suite of digital health apps work across CGM systems to provide you and your patients with actionable, real-time glucose insights. Explore Dexcom Apps ### Dexcom CLARITY Clarity makes insights intuitive for you and your patients by turning data, trends, and patterns into digestible summaries that inspire action. Experience CLARITY

• About Dexcom

  ETEN # Empowering people to take control of their diabetes Dexcom is a pioneer in Continuous Glucose Monitoring (CGM). Since 1999, we have developed innovative technology that has transformed how people manage diabetes. Our products are part of people’s daily lives, empowering them to live confidently and feel more in control, free to pursue their dreams. What is CGM? ## A leader in diabetes technology [...] What is CGM? ## A leader in diabetes technology Here at Dexcom we’ve spent the last 20 years innovating and developing simpler and better ways for people with all diabetes types to track and manage their diabetes. When we first started, the only way to measure glucose levels was to finger prick.\ It gave us a snapshot, not a story, which made it difficult to understand glucose levels and trends over time for diabetes control. #### Introduced first CGM system to the world in 2006 #### More than 8,000 employees acrss the globe #### Available in 52 countries worldwide† #### Helped eliminate more than 11 billion finger pricks\ ## Who we serve [...] Act in the best interest of our community. #### Think big Use technology to revolutionise diabetes care. #### Be dependable Inspire confidence within our community and in one another. References: \ If your glucose alerts and readings Dexcom ONE do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. † Data correct as of December, 2020. ‡ Dexcom products are suitable for ages 2 years + including pregnant women. About Dexcom Learn about CGMDownloads & Guides Dexcom ONE+ Shop Dexcom ONE+ SensorDexcom ONE+ ReceiverDexcom ONE+ Monthly SubscriptionDexcom ONE+ Quarterly Subscription More Information Safety InformationPrivacy PolicyTerms of UseContact usSensor replacement policyDeclaration of Conformity

• Country

  United States

• Instance Of

  Q891723

• Headquarters

  San Diego

• Inception Date

  1/1/1999